Bone and Cancer
Bone and Cancer
Bone and CancerBone and Cancer Foundation, PO Box 287452 Bone and Cancer New York, NY 10128-0025  
Toll Free: 888 862-0999 Bone and Cancer Email: bcfdn@aol.com  
Bone and Cancer

Clinical Trials

ProAmatine (midodrine)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved September 1996

Specific Treatments:

hypotension

General Information

ProAmatine has been approved for the treatment of hypotension.

Additional Information

Hypotension is a low blood pressure condition characterized by a sudden drop in blood pressure upon assuming an upright posture. The condition is often accompanied by dizziness, lightheadedness, and fainting, which in older patients often leads to traumatic injury associated with falls.

 How To Order Publications:
  Glossary
  FAQ

Information About

Clinical Trials



 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 


  Copyright 2011 - The Bone and Cancer Foundation